Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725575 | SCV000337896 | uncertain significance | not provided | 2015-12-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725575 | SCV000520950 | likely benign | not provided | 2019-10-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082980 | SCV000759714 | likely benign | X-linked Emery-Dreifuss muscular dystrophy | 2023-12-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002338845 | SCV002641214 | likely benign | Cardiovascular phenotype | 2020-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001795484 | SCV002034613 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000725575 | SCV002038452 | likely benign | not provided | no assertion criteria provided | clinical testing |